3 Stocks Pushing The Computer Software & Services Industry Lower

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

Two out of the three major indices are trading lower today with the Dow Jones Industrial Average ( ^DJI) trading down 10 points (-0.1%) at 15,618 as of Friday, Aug. 2, 2013, 12:50 PM ET. The NYSE advances/declines ratio sits at 1,354 issues advancing vs. 1,554 declining with 118 unchanged.

The Computer Software & Services industry currently sits up 0.1% versus the S&P 500, which is down 0.1%. On the negative front, top decliners within the industry include Activision Blizzard ( ATVI), down 2.5%, and Automatic Data Processing ( ADP), down 0.5%. Top gainers within the industry include Autodesk ( ADSK), up 2.1%, Catamaran ( CTRX), up 1.6% and Salesforce.com ( CRM), up 0.6%.

TheStreet would like to highlight 3 stocks pushing the industry lower today:

3. Gartner ( IT) is one of the companies pushing the Computer Software & Services industry lower today. As of noon trading, Gartner is down $3.71 (-6.0%) to $58.37 on heavy volume. Thus far, 786,401 shares of Gartner exchanged hands as compared to its average daily volume of 328,000 shares. The stock has ranged in price between $57.65-$59.62 after having opened the day at $57.84 as compared to the previous trading day's close of $62.08.

Gartner, Inc. provides independent and objective research and analysis on information technology (IT), computer hardware, software, communications, and related technology industries. Gartner has a market cap of $5.6 billion and is part of the technology sector. Shares are up 30.4% year to date as of the close of trading on Thursday. Currently there are 5 analysts that rate Gartner a buy, no analysts rate it a sell, and 4 rate it a hold.

TheStreet Ratings rates Gartner as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, growth in earnings per share, good cash flow from operations, solid stock price performance and increase in net income. We feel these strengths outweigh the fact that the company has had somewhat disappointing return on equity. Get the full Gartner Ratings Report now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

2. As of noon trading, Accenture ( ACN) is down $0.50 (-0.7%) to $74.35 on average volume. Thus far, 1.3 million shares of Accenture exchanged hands as compared to its average daily volume of 3.4 million shares. The stock has ranged in price between $74.00-$74.47 after having opened the day at $74.22 as compared to the previous trading day's close of $74.85.

Accenture plc provides management consulting, technology, and business process outsourcing services worldwide. Accenture has a market cap of $47.6 billion and is part of the technology sector. Shares are up 11.0% year to date as of the close of trading on Thursday. Currently there are 12 analysts that rate Accenture a buy, 1 analyst rates it a sell, and 8 rate it a hold.

TheStreet Ratings rates Accenture as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, solid stock price performance, impressive record of earnings per share growth and compelling growth in net income. We feel these strengths outweigh the fact that the company shows low profit margins. Get the full Accenture Ratings Report now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

1. As of noon trading, International Business Machines ( IBM) is down $1.51 (-0.8%) to $194.30 on average volume. Thus far, 1.7 million shares of International Business Machines exchanged hands as compared to its average daily volume of 4.0 million shares. The stock has ranged in price between $193.22-$195.50 after having opened the day at $195.50 as compared to the previous trading day's close of $195.81.

International Business Machines Corporation provides information technology (IT) products and services worldwide. The company operates in five segments: Global Technology Services, Global Business Services, Software, Systems and Technology, and Global Financing. International Business Machines has a market cap of $216.3 billion and is part of the technology sector. Shares are up 1.8% year to date as of the close of trading on Thursday. Currently there are 10 analysts that rate International Business Machines a buy, no analysts rate it a sell, and 11 rate it a hold.

TheStreet Ratings rates International Business Machines as a buy. The company's strengths can be seen in multiple areas, such as its notable return on equity, expanding profit margins and increase in stock price during the past year. We feel these strengths outweigh the fact that the company has had sub par growth in net income. Get the full International Business Machines Ratings Report now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

If you are interested in one of these 3 stocks, ETFs may be of interest. Investors who are bullish on the computer software & services industry could consider iShares S&P NA Tech Software Idx ( IGV) while those bearish on the computer software & services industry could consider ProShares Ultra Short Technology ( REW).

null

More from Markets

Dow Gets Swept Into Nasty Reversal Even as Nasdaq Posts New Record

Dow Gets Swept Into Nasty Reversal Even as Nasdaq Posts New Record

Zoom CEO Eric Yuan Leads Glassdoor's List of Top 100 CEOs

Zoom CEO Eric Yuan Leads Glassdoor's List of Top 100 CEOs

REPLAY: Jim Cramer on Fed Rate Hikes, Oil Prices and Starbucks Worries

REPLAY: Jim Cramer on Fed Rate Hikes, Oil Prices and Starbucks Worries

3 Must Reads on the Market From TheStreet's Top Columnists

3 Must Reads on the Market From TheStreet's Top Columnists

Purdue Pharma Unloads Sales Staff, Transitioning From Painkiller Focus

Purdue Pharma Unloads Sales Staff, Transitioning From Painkiller Focus